Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William F Goins

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging moleculeKenji Nakano, Ryutaro Asano, Kouhei Tsumoto, et al.
Virology|April 17, 2015
Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgiaJean-Marc G Guedon, Michael B Yee, Mingdi Zhang, et al.
Journal of Virology|August 17, 2004
Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purificationCanping Jiang, James B Wechuck, William F Goins, et al.
The Journal of Urology|November 24, 2012
Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in ratsYasuhito Funahashi, Tomohiko Oguchi, William F Goins, et al.
Diabetes|September 28, 2004
Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathyKatsumi Sasaki, Michael B Chancellor, William F Goins, et al.
Journal of Virology|February 15, 2005
Equine herpesvirus 1 utilizes a novel herpesvirus entry receptorArthur R Frampton, William F Goins, Justus B Cohen, et al.
Journal of Virology|January 9, 2009
Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognitionHiroaki Uchida, Waris A Shah, Ali Ozuer, et al.
Journal of Virology|December 15, 2005
Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein DHeechung Kwon, Qing Bai, Hyun-Jung Baek, et al.
Veterinary Microbiology|August 29, 2009
Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cellsArthur R Frampton, Hiroaki Uchida, Jens von Einem, et al.
Neurourology and Urodynamics|December 1, 2018
The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociceptionTsuyoshi Majima, Kenichi Mori, Katsumi Kadekawa, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging moleculeKenji Nakano, Ryutaro Asano, Kouhei Tsumoto, et al.
Virology|April 17, 2015
Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgiaJean-Marc G Guedon, Michael B Yee, Mingdi Zhang, et al.
Journal of Virology|August 17, 2004
Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purificationCanping Jiang, James B Wechuck, William F Goins, et al.
The Journal of Urology|November 24, 2012
Herpes simplex virus vector mediated gene therapy of tumor necrosis factor-α blockade for bladder overactivity and nociception in ratsYasuhito Funahashi, Tomohiko Oguchi, William F Goins, et al.
Diabetes|September 28, 2004
Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathyKatsumi Sasaki, Michael B Chancellor, William F Goins, et al.
Journal of Virology|February 15, 2005
Equine herpesvirus 1 utilizes a novel herpesvirus entry receptorArthur R Frampton, William F Goins, Justus B Cohen, et al.
Journal of Virology|January 9, 2009
Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognitionHiroaki Uchida, Waris A Shah, Ali Ozuer, et al.
Journal of Virology|December 15, 2005
Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein DHeechung Kwon, Qing Bai, Hyun-Jung Baek, et al.
Veterinary Microbiology|August 29, 2009
Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cellsArthur R Frampton, Hiroaki Uchida, Jens von Einem, et al.
Neurourology and Urodynamics|December 1, 2018
The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociceptionTsuyoshi Majima, Kenichi Mori, Katsumi Kadekawa, et al.
Pageof 8